Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 3

1(20.0%)

Phase 4

1(20.0%)

Phase 2

1(20.0%)

5Total

N/A(2)

Phase 3(1)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05553236Not ApplicableRecruiting

Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis

Role: collaborator

NCT03500172Not ApplicableCompleted

HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study)

Role: collaborator

NCT04838795Phase 3Completed

Sisonke (Together): OPEN LABEL TRIAL COVID-19

Role: collaborator

NCT05277298Unknown

Household Study of COVID-19, Influenza and RSV Burden, Transmission Dynamics and Viral Interaction in South Africa

Role: lead

NCT02556242Phase 4Completed

Targeted Indoor Residual Spraying Against Malaria

Role: collaborator

NCT02984579Completed

Line Probe Assay Evaluation Study

Role: collaborator

NCT02519803Unknown

A Prospective Household Observational Cohort Study of Influenza, Respiratory Syncytial Virus and Other Respiratory Pathogens Community Burden and Transmission Dynamics in South Africa

Role: lead

NCT02465190Unknown

Effectiveness of Trivalent Inactivated Influenza Maternal Vaccination Among Pregnant Women and Their Newborns in South Africa

Role: lead

NCT00164424Phase 2Completed

Episodic Acyclovir Therapy for Genital Ulcers

Role: collaborator

All 9 trials loaded